Amkor (AMKR) File 144: Proposed Sale of 11,792 Common Shares on NASDAQ
Rhea-AI Filing Summary
Form 144 notice for Amkor Technology, Inc. (AMKR) shows a proposed sale of 11,792 common shares by an insider through Morgan Stanley Smith Barney, with an aggregate market value of $294,800 based on the filing. The shares represent part of previously acquired awards (restricted stock and performance shares) granted by the issuer between August 2024 and February 2025. The filing states the approximate sale date as 09/09/2025 on the NASDAQ and confirms no securities were reported sold by this person in the past three months.
Positive
- Disclosed proposed sale amount: 11,792 shares with an aggregate market value of $294,800
- Clear provenance of shares: detailed acquisition dates and grant types (restricted stock and performance shares)
- Broker identified: Morgan Stanley Smith Barney LLC listed for execution on NASDAQ
- No recent sales reported: the filer reported "Nothing to Report" for sales in the past three months
Negative
- None.
Insights
TL;DR: Routine insider sale notice disclosing ~11.8k shares worth $295k, reflecting scheduled disposition of recently issued equity awards.
This Form 144 documents a proposed sale under Rule 144 rather than an open-market ad hoc sale; the securities originated from restricted stock and performance share grants dated between 08/13/2024 and 02/24/2025. The broker is identified and the planned execution date is provided, which improves transparency for investors monitoring insider activity. The size of the sale ($294,800) is modest relative to typical market-capitalization-scale insider transactions and the filing reports no sales in the prior three months.
TL;DR: Disclosure aligns with Rule 144 reporting obligations and includes acquisition dates and grant types for the securities to be sold.
The filing lists acquisition types as restricted stock and performance shares, with acquisition and payment dates for each lot, satisfying Rule 144 transparency expectations. The signer affirms no undisclosed material adverse information. This filing is procedural and provides the necessary public record for compliance and insider-trading oversight.